NEOANTIGENID
associated with 48 other trademarks
Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequenc...

Words that describe this trademark:

data analysis interpretation  genome sequencing  assay development  sequencing data  analysis interpretation  amplifying  preparing  interpretation  development  labeling 

Serial Number:

90080382

Mark:

NEOANTIGENID

Status:

Registered

Status Date:

06-29-2021

Filing Date:

Registration Number:

6405467

Registration Date:

06-29-2021

Goods and Services:

Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development Analysis of cells, amino acids, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment

Mark Description:

N/A

Class:

Medical services

Type of Mark:

Servicemark

Published for Opposition Date:

N/A

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

KILPATRICK TOWNSEND & STOCKTON LLP

Correspondent Name:

Recent Trademark filings by this company